Workflow
TON ecosystem
icon
Search documents
Public Gateway to Telegram Economy: AlphaTON Executive Chairman Enzo Villani, Live at Nasdaq
Yahoo Finance· 2025-12-10 20:42
Exec Edge hosted a fireside chat on Dec. 8 at Nasdaq MarketSite with Enzo Villani, Executive Chairman and Chief Investment Officer of AlphaTON Capital Corp. (Nasdaq: ATON). The in-person interview was joined by Editor-in-Chief John Jannarone and they discussed how the company is building what it describes as the public gateway to the Telegram economy, ATON’s recent moves like acquiring Forbes, investing in GPU infrastructure for Telegram’s Cacoon AI network, pursuing GAMEE’s gaming platform, tokenizing heal ...
AlphaTON Capital to Reveal 2026 Technical Strategy in Landmark Inaugural AMA Event
Globenewswire· 2025-12-05 17:19
Core Insights - AlphaTON Capital is hosting its inaugural "Ask Me Anything" (AMA) event on December 11, 2025, aimed at providing insights into its technology and strategy within the Telegram ecosystem [1][8] - The event will feature Chief Technology Officer Logan Golema and his development team, focusing on the foundational infrastructure for future Telegram users [3][9] - Attendees will gain insights into AlphaTON's revenue generation strategies, technical milestones for 2026, a major product announcement, and details about the upcoming HackATON RoadShow [7][9] Event Details - The AMA will take place on December 11, 2025, at 4:30 PM UTC, accessible via X Space and Telegram Voice Chat [8] - Questions for the AMA can be submitted in advance to guide the discussion [5] Company Overview - AlphaTON Capital (NASDAQ: ATON) is a leading technology public company focused on scaling the Telegram super app, targeting an addressable market of 1 billion monthly active users [9] - The company employs a comprehensive M&A and treasury strategy, including token acquisition and strategic investments, to ensure sustainable returns for shareholders [9] - AlphaTON Capital is involved in network validation, staking operations, and the development of Telegram-based applications, while also engaging in drug development for immunotherapy [10]